These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis]. Postnikov SS Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276 [TBL] [Abstract][Full Text] [Related]
7. Ciprofloxacin safety in a pediatric population. Jick S Pediatr Infect Dis J; 1997 Jan; 16(1):130-3; discussion 133-4, 160-2. PubMed ID: 9002123 [TBL] [Abstract][Full Text] [Related]
8. Safety profile of quinolone antibiotics in the pediatric population. Grady R Pediatr Infect Dis J; 2003 Dec; 22(12):1128-32. PubMed ID: 14688586 [TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis. Schaad UB; Wedgwood J; Ruedeberg A; Kraemer R; Hampel B Pediatr Infect Dis J; 1997 Jan; 16(1):106-11; discussion 123-6. PubMed ID: 9002119 [TBL] [Abstract][Full Text] [Related]
10. Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient. Samuelson WM; Pleasants RA; Whitaker MS Ann Pharmacother; 1993 Mar; 27(3):302-3. PubMed ID: 8453165 [TBL] [Abstract][Full Text] [Related]
11. Ciprofloxacin in children: is arthropathy a limitation? Singh UK; Sinha RK; Prasad B; Chakrabarti B; Sharma SK Indian J Pediatr; 2000 May; 67(5):386-7. PubMed ID: 10885214 [TBL] [Abstract][Full Text] [Related]
12. Ciprofloxacin-induced acute renal failure in a patient with cystic fibrosis. Bald M; Ratjen F; Nikolaizik W; Wingen AM Pediatr Infect Dis J; 2001 Mar; 20(3):320-1. PubMed ID: 11303842 [TBL] [Abstract][Full Text] [Related]
13. Acute reversible arthropathy in a pediatric patient with cancer treated with a short course of ciprofloxacin for febrile neutropenia. Mullen CA; Petropoulos D; Rytting M; Jeha S; Zipf T; Roberts WM; Rolston KV J Pediatr Hematol Oncol; 1998; 20(5):516-7. PubMed ID: 9787333 [No Abstract] [Full Text] [Related]
14. Use of the quinolones in paediatrics. Schaad UB Drugs; 1993; 45 Suppl 3():37-41. PubMed ID: 7689449 [TBL] [Abstract][Full Text] [Related]
15. Use of the new quinolones in pediatrics. Schaad UB Isr J Med Sci; 1994; 30(5-6):463-8. PubMed ID: 8034505 [TBL] [Abstract][Full Text] [Related]
16. Tolerance and safety of ciprofloxacin in paediatric patients. Black A; Redmond AO; Steen HJ; Oborska IT J Antimicrob Chemother; 1990 Dec; 26 Suppl F():25-9. PubMed ID: 2292542 [TBL] [Abstract][Full Text] [Related]
17. Potential quinolone-induced cartilage toxicity in children. Camp KA; Miyagi SL; Schroeder DJ Ann Pharmacother; 1994 Mar; 28(3):336-8. PubMed ID: 8193422 [No Abstract] [Full Text] [Related]
18. Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning. Redmond A; Sweeney L; MacFarland M; Mitchell M; Daggett S; Kubin R J Int Med Res; 1998 Dec; 26(6):304-12. PubMed ID: 10399112 [TBL] [Abstract][Full Text] [Related]
19. [Comparative yearly growth rate of children with mucoviscidosis treated and not treated with ciprofloxacin:clinicomorphological comparisons]. Postnikov CC; Semiakin SI; Nazhimov VP; Kapranov NI Antibiot Khimioter; 2001; 46(10):11-3. PubMed ID: 11881187 [TBL] [Abstract][Full Text] [Related]
20. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Salam MA; Dhar U; Khan WA; Bennish ML Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]